It was found that 63.33% (n = 38) and 50% (n = 3) of cutaneous and uveal melanomas, respectively, did not express p16INK4α mRNA, and 15% (n = 9) of cutaneous melanomas displayed expression levels below the cutoff point established in healthy samples. Here, CDKN2A is linked to cutaneous melanoma.